Literature DB >> 28145029

Clinicopathological importance of anterior prostate cancer in Japanese Men.

Shun Sato1, Hiroyuki Takahashi1, Takahiro Kimura2, Shin Egawa2, Bungo Furusato3, Masahiro Ikegami1.   

Abstract

Prostate cancer of transition zone origin or anterior location has been recognized as infrequent, smaller in size and indolent, whereas, our previous report showed that transition zone/anterior cancer was frequently experienced in Japanese men. The current study was conducted to show clinicopathological characteristics of transition zone/anterior cancer. A total of 201 radical prostatectomy specimens were categorized as cancer of anterior or posterior prostate where more than two thirds of the tumor existed in the specific area. Clinicopathological characteristics including Gleason score, pathological stage, lymph node metastasis, extraprostatic extension, surgical incision into the prostate (shown as pT2+), and surgical margin status were compared between anterior and posterior cases. Cases were divided as 83, 73, and 45 of anterior, posterior cancer, and no dominance, respectively. Anterior cancers included significant numbers of high grade tumors (13/83 cases: 15.7%), which was less than posterior cancers (28.8%: 21/73). The cases in pT2+ were significantly more frequent in anterior cases than posterior ones (22.9% vs. 4.1%). No seminal vesicle invasion was shown in anterior cases. Thus, although anterior cancers are less aggressive than posterior cancers, a significant numbers of clinically important cancers were located in the anterior portion in Japanese men.
© 2017 Japanese Society of Pathology and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Gleason score; prostate cancer; surgical pathology; transition zone; tumor location

Mesh:

Year:  2017        PMID: 28145029     DOI: 10.1111/pin.12513

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  3 in total

1.  Transition zone prostate cancer is associated with better clinical outcomes than peripheral zone cancer.

Authors:  Shun Sato; Takahiro Kimura; Hajime Onuma; Shin Egawa; Hiroyuki Takahashi
Journal:  BJUI Compass       Date:  2020-10-06

2.  Comparison of malignancy and spatial distribution between latent and clinical prostate cancer: an 8-year biopsy study.

Authors:  Liang Zhen; Zhou Zhien; Huang Hanzi; Wu Xingcheng; Xiao Yu; Wang Wenze; Zuo Yuzhi; Chen Yuliang; Zhou Yi; Yan Weigang
Journal:  Eur J Med Res       Date:  2022-09-10       Impact factor: 4.981

3.  External validation of the Briganti 2019 nomogram to identify candidates for extended pelvic lymph node dissection among patients with high-risk clinically localized prostate cancer.

Authors:  Eri Fukagawa; Shinya Yamamoto; Sachiko Ohde; Kasumi Kaneko Yoshitomi; Kosuke Hamada; Yusuke Yoneoka; Motohiro Fujiwara; Ryo Fujiwara; Tomohiko Oguchi; Yoshinobu Komai; Noboru Numao; Takeshi Yuasa; Iwao Fukui; Junji Yonese
Journal:  Int J Clin Oncol       Date:  2021-06-12       Impact factor: 3.402

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.